These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1214 related articles for article (PubMed ID: 12816671)

  • 41. [Diagnostic and therapeutic concepts of HPV infection in HIV-positive women].
    Küppers V; von Eckardstein S; Adomeit A; Wingartz C; Bodden-Heidrich R; Koldovsky U; Bender HG
    Zentralbl Gynakol; 1999; 121(1):27-30. PubMed ID: 10091310
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV).
    Castle PE; Hillier SL; Rabe LK; Hildesheim A; Herrero R; Bratti MC; Sherman ME; Burk RD; Rodriguez AC; Alfaro M; Hutchinson ML; Morales J; Schiffman M
    Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1021-7. PubMed ID: 11588127
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Estimation of HPV infection presence in cytological smears in a group of asymptomatic women].
    Łukaszuk K; Liss J; Zalewski J; Roter M; Brzóska B; Debniak J
    Wiad Lek; 2001; 54(9-10):508-15. PubMed ID: 11816294
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human papillomavirus DNA remains detectable longer than related cervical cytologic abnormalities.
    Schiffman M; Wheeler CM; Castle PE;
    J Infect Dis; 2002 Oct; 186(8):1169-72. PubMed ID: 12355370
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cervical smears in assessment of the natural history of human papillomavirus infections in prospectively followed women.
    Syrjänen KJ; Mäntyjärvi R; Väyrynen M; Yliskoski M; Syrjänen SM; Saarikoski S; Nurmi T; Parkkinen S; Castrén O
    Acta Cytol; 1987; 31(6):855-65. PubMed ID: 2827414
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Papillomavirus-induced anogenital lesions in 121 HIV seropositive men. Clinical, histological, viral study, and evolution].
    Voltz JM; Drobacheff C; Derancourt C; Coumes-Marquet S; Mougin C; Laurent R
    Ann Dermatol Venereol; 1999 May; 126(5):424-9. PubMed ID: 10434106
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study.
    Giuliano AR; Harris R; Sedjo RL; Baldwin S; Roe D; Papenfuss MR; Abrahamsen M; Inserra P; Olvera S; Hatch K
    J Infect Dis; 2002 Aug; 186(4):462-9. PubMed ID: 12195372
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A cumulative case-control study of risk factor profiles for oncogenic and nononcogenic cervical human papillomavirus infections.
    Rousseau MC; Franco EL; Villa LL; Sobrinho JP; Termini L; Prado JM; Rohan TE
    Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):469-76. PubMed ID: 10815691
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Follow-up of high risk, human papillomavirus (HPV)-positive patients with cancer of the uterine cervix].
    Hernádi Z; Sápy T; Kónya J; Veress G; Czeglédy J
    Orv Hetil; 1997 May; 138(20):1249-53. PubMed ID: 9244858
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vaginal dysplastic lesions in women with hysterectomy and receiving radiotherapy are linked to high-risk human papillomavirus.
    Barzon L; Pizzighella S; Corti L; Mengoli C; Palù G
    J Med Virol; 2002 Jul; 67(3):401-5. PubMed ID: 12116034
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incidence, clearance and predictors of human papillomavirus infection in women.
    Sellors JW; Karwalajtys TL; Kaczorowski J; Mahony JB; Lytwyn A; Chong S; Sparrow J; Lorincz A;
    CMAJ; 2003 Feb; 168(4):421-5. PubMed ID: 12591782
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse).
    Kjaer SK; Chackerian B; van den Brule AJ; Svare EI; Paull G; Walbomers JM; Schiller JT; Bock JE; Sherman ME; Lowy DR; Meijer CL
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):101-6. PubMed ID: 11219765
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of risk factors and human papillomavirus (HPV) related pathogenetic mechanisms of CIN in HIV-positive and HIV-negative women. Study design and baseline data of the HPV-PathogenISS study.
    Branca M; Costa S; Mariani L; Sesti F; Agarossi A; di Carlo A; Galati M; Benedetto A; Ciotti M; Giorgi C; Criscuolo A; Valieri M; Favalli C; Paba P; Santini D; Piccione E; Alderisio M; De Nuzzo M; di Bonito L; Syrjänen K
    Eur J Gynaecol Oncol; 2004; 25(6):689-98. PubMed ID: 15597844
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A 7.5-year prospective study of longer than 18 months type-specific human papillomavirus persistence in a routine cytology-based cervical screening population of about 31,000 women in West Germany.
    Kovács K; Varnai AD; Bollmann M; Bankfalvi A; Szendy M; Speich N; Schmitt C; Pajor L; Bollmann R; Hildenbrand R
    Eur J Cancer Prev; 2009 Aug; 18(4):307-15. PubMed ID: 19436214
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Natural history of cervical human papillomavirus (HPV) infections based on prospective follow-up.
    Syrjänen K; Väyrynen M; Saarikoski S; Mäntyjärvi R; Parkkinen S; Hippeläinen M; Castren O
    Br J Obstet Gynaecol; 1985 Nov; 92(11):1086-92. PubMed ID: 2998436
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Repeated evaluation of human papillomavirus 16 status in cervical swabs of young women with a history of normal Papanicolaou smears.
    Schneider A; Kirchhoff T; Meinhardt G; Gissmann L
    Obstet Gynecol; 1992 May; 79(5 ( Pt 1)):683-8. PubMed ID: 1314360
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genotype-specific persistence of genital human papillomavirus (HPV) infections in women followed for 6 years in the Finnish Family HPV Study.
    Louvanto K; Rintala MA; Syrjänen KJ; Grénman SE; Syrjänen SM
    J Infect Dis; 2010 Aug; 202(3):436-44. PubMed ID: 20557239
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The association between pregnancy and human papilloma virus prevalence.
    Smith EM; Johnson SR; Jiang D; Zaleski S; Lynch CF; Brundage S; Anderson RD; Turek LP
    Cancer Detect Prev; 1991; 15(5):397-402. PubMed ID: 1661203
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro cytopathogenicity of the human immunodeficiency virus (HIV)-1 predicts survival in HIV-infected hemophiliacs independent from CD4 cell count.
    Rockstroh JK; Woitas RP; Brackmann HH; Kupfer B; Kaiser R; Schneweis KE; Sudhop T; Spengler U
    Eur J Med Res; 1998 May; 3(5):223-30. PubMed ID: 9580568
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cervicovaginal shedding of TT virus in HIV-infected women.
    Calcaterra S; Zaniratti MS; Serraino D; Peroni M; Abbate I; Cappiello G; Piselli P; Pavia C; Rezza G; Ippolito G; Capobianchi MR
    J Hum Virol; 2001; 4(6):343-5. PubMed ID: 12082401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 61.